These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 16339197

  • 1. Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells.
    Acconcia F, Barnes CJ, Kumar R.
    Endocrinology; 2006 Mar; 147(3):1203-12. PubMed ID: 16339197
    [Abstract] [Full Text] [Related]

  • 2. Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.
    Flamini MI, Sanchez AM, Goglia L, Tosi V, Genazzani AR, Simoncini T.
    Mol Hum Reprod; 2009 Oct; 15(10):675-85. PubMed ID: 19541800
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 10. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M.
    Steroids; 2005 Mar; 70(5-7):372-81. PubMed ID: 15862820
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
    Wang Z, Kyo S, Maida Y, Takakura M, Tanaka M, Yatabe N, Kanaya T, Nakamura M, Koike K, Hisamoto K, Ohmichi M, Inoue M.
    Oncogene; 2002 May 16; 21(22):3517-24. PubMed ID: 12032853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
    Sun Y, Wang C, Yang H, Ma X.
    Eur J Cancer Prev; 2014 Sep 16; 23(5):418-24. PubMed ID: 25068805
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    Tsai CL, Wu HM, Lin CY, Lin YJ, Chao A, Wang TH, Hsueh S, Lai CH, Wang HS.
    PLoS One; 2013 Sep 16; 8(9):e72999. PubMed ID: 24039841
    [Abstract] [Full Text] [Related]

  • 20. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC, Burger CW, Kühne LC, Hanifi-Moghaddam P, Blok LJ.
    J Soc Gynecol Investig; 2005 Oct 16; 12(7):e55-67. PubMed ID: 16202921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.